| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.2 | 0.4 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.035 | 0.5 |